
|Articles|April 1, 2018
- Pharmaceutical Executive-04-01-2018
- Volume 38
- Issue 4
Pharmaceutical Executive, April 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Rewriting Pharma’s Talent Blueprintalmost 8 years ago
Trading Big Pharma for Small Startupalmost 8 years ago
HEOR Education: Evolving the Skill Setalmost 8 years ago
Drug Marketing and Advertising Under Firealmost 8 years ago
A Watchful Eye on AIalmost 8 years ago
The New Talent Trajectoryalmost 8 years ago
HBA's Woman of the Year 2018almost 8 years ago
The New (Augmented) Reality in the Life Sciencesalmost 8 years ago
Med Affairs Building Up its Strategic Musclealmost 8 years ago
The Top Barriers to Patient PersistenceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5




